BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30724352)

  • 1. The sentinel node biopsy has come of age.
    McGregor JM
    Br J Dermatol; 2019 Aug; 181(2):423. PubMed ID: 30724352
    [No Abstract]   [Full Text] [Related]  

  • 2. Stage IIIa Melanoma and Impact of Multiple Positive Lymph Nodes on Survival.
    Woeste MR; McMasters KM; Egger ME
    J Am Coll Surg; 2021 Apr; 232(4):517-524.e1. PubMed ID: 33316426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double primary malignant melanoma on the forearm and the chest with detection of common axillary sentinel lymph nodes.
    Nakamura Y; Ishizuki S; Iwasaki R; Ishitsuka Y; Watanabe R; Saito A; Furuta J; Okiyama N; Fujisawa Y
    J Dermatol; 2020 May; 47(5):e187-e188. PubMed ID: 32133678
    [No Abstract]   [Full Text] [Related]  

  • 4. Sentinel Lymph Node Biopsy: Past and Present Implications for the Management of Cutaneous Melanoma with Nodal Metastasis.
    Gonzalez A
    Am J Clin Dermatol; 2018 Nov; 19(Suppl 1):24-30. PubMed ID: 30374897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glimpse of future management of melanoma.
    Cochran AJ
    Arch Dermatol; 2009 Oct; 145(10):1176-7. PubMed ID: 19841407
    [No Abstract]   [Full Text] [Related]  

  • 6. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
    Broman KK; Hughes TM; Dossett LA; Sun J; Carr MJ; Kirichenko DA; Sharma A; Bartlett EK; Nijhuis AA; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma J; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras RM; Teras J; Farrow NE; Beasley GM; Hui JY; Been L; Kruijff S; Boulware D; Sarnaik AA; Sondak VK; Zager JS;
    J Am Coll Surg; 2021 Apr; 232(4):424-431. PubMed ID: 33316427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of disease free survival in cutaneous melanoma patients subject to sentinel lymph node biopsy.
    Ɓobaziewicz W; Szloch J; Wajda J; Legkiy O; Marczyk E; Wysocki W
    Pol Przegl Chir; 2020 Mar; 92(3):15-21. PubMed ID: 32759393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node tumor burden in prediction of prognosis in melanoma patients.
    Palve J; Ylitalo L; Luukkaala T; Jernman J; Korhonen N
    Clin Exp Metastasis; 2020 Apr; 37(2):365-376. PubMed ID: 32076905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counterpoint: Surgical Management of Lymph Node Basin in Sentinel Lymph Node-Positive Melanoma.
    Ross MI
    Oncology (Williston Park); 2016 Oct; 30(10):891, 893-5. PubMed ID: 27753055
    [No Abstract]   [Full Text] [Related]  

  • 10. Point: Surgical Management of Lymph Node Basin in Sentinel Lymph Node-Positive Melanoma.
    Sarnaik AA; Zager JS; Sondak VK
    Oncology (Williston Park); 2016 Oct; 30(10):891-2, 895. PubMed ID: 27753054
    [No Abstract]   [Full Text] [Related]  

  • 11. Sentinel-node biopsy in melanoma.
    Lipsker D
    N Engl J Med; 2007 Jan; 356(4):419; author reply 419-21. PubMed ID: 17256190
    [No Abstract]   [Full Text] [Related]  

  • 12. Does Wide Excisional Biopsy in Skin Cancer Prevent Finding The Real Sentinel Lymph Node?
    Sirvan SS; Demir IA; Irmak F; Kafi M; Budak K; Karsidag S
    J Invest Surg; 2020 Sep; 33(8):741-747. PubMed ID: 30892109
    [No Abstract]   [Full Text] [Related]  

  • 13. Sentinel lymph node biopsy in melanoma: controversies and current guidelines.
    Durham AB; Wong SL
    Future Oncol; 2014 Feb; 10(3):429-42. PubMed ID: 24559449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guidelines for stage I to III melanoma].
    Guillot B; Dalac S; Denis M; Dupuy A; Emile JF; De La Fouchardiere A; Hindie E; Jouary T; Lassau N; Mirabel X; Piperno Neumann S; De Raucourt S; Vanwijck R
    Bull Cancer; 2016 Sep; 103(9):743-52. PubMed ID: 27456259
    [No Abstract]   [Full Text] [Related]  

  • 15. When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'.
    Gyorki DE; Barbour A; Hanikeri M; Mar V; Sandhu S; Thompson JF
    Australas J Dermatol; 2017 Nov; 58(4):274-277. PubMed ID: 28718222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management of melanoma.
    Dunki-Jacobs EM; Callender GG; McMasters KM
    Curr Probl Surg; 2013 Aug; 50(8):351-82. PubMed ID: 23849560
    [No Abstract]   [Full Text] [Related]  

  • 17. Complication rates of completion lymphadenectomy following positive sentinel lymph node biopsy versus therapeutic lymphadenectomy in melanoma.
    Smith JR; Wilson A; Stone C
    J Plast Reconstr Aesthet Surg; 2016 Jul; 69(7):1011-2. PubMed ID: 27184594
    [No Abstract]   [Full Text] [Related]  

  • 18. Time to reconsider the role of sentinel lymph node biopsy in melanoma.
    Bigby M; Zagarella S; Sladden M; Popescu CM
    J Am Acad Dermatol; 2019 Apr; 80(4):1168-1171. PubMed ID: 30471314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local lymph node micrometastasis in a patient with negative sentinel lymph node biopsies after lymphatic mapping with wide local excision of primary melanoma on the head/neck area.
    Querfeld C; Wayne JD; Wei JJ; Abdul-Nabi A; Gerami P
    Am J Dermatopathol; 2011 Oct; 33(7):745-8. PubMed ID: 21946765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node evaluations.
    Zitelli JA
    Adv Dermatol; 2007; 23():47-60. PubMed ID: 18159895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.